Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-18-000002

CEO acquired 697,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BUNKA CHRISTOPHER CEO 2018-06-18 Option exercise +450,000 $0.14 $63,000 6,081,844 I
BUNKA CHRISTOPHER CEO 2018-06-18 Option exercise +247,500 $0.09 $22,275 7,512,554 D
Derivatives
BUNKA CHRISTOPHER CEO 2018-06-18 Option exercise · Stock Options −247,500 $0.09 $22,275 1,250,000 D
BUNKA CHRISTOPHER CEO 2018-06-18 Option exercise · Warrants −450,000 $0.14 $63,000 0 I
Loading xslF345X03/primary_doc.xml…